Important Group Differences on the Functional Assessment of Cancer Therapy–Kidney Symptom Index Disease-Related Symptoms (FKSI-DRS) in Patients with Metastatic Renal Cell Carcinoma
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.328
https://www.valueinhealthjournal.com/article/S1098-3015(17)30662-9/fulltext
Title :
Important Group Differences on the Functional Assessment of Cancer Therapy–Kidney Symptom Index Disease-Related Symptoms (FKSI-DRS) in Patients with Metastatic Renal Cell Carcinoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30662-9&doi=10.1016/j.jval.2017.08.328
First page :
A456
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
303